Literature DB >> 21696988

The neurology of biotinidase deficiency.

Barry Wolf1.   

Abstract

Biotinidase deficiency is an autosomal recessively inherited metabolic disorder in which the enzyme, biotinidase, is defective and the vitamin, biotin, is not recycled. Individuals with biotinidase deficiency, if not treated with biotin, usually exhibit neurological and cutaneous abnormalities. Biotin treatment can ameliorate or prevent symptoms. Biotinidase deficiency meets the major criteria for inclusion in newborn screening programs. With the advent of universal newborn screening for the disorder, the "window-of-opportunity" to characterize the consequences of the untreated disease is essentially gone. To understand the neurology of biotinidase deficiency, we must depend on what is already known about symptomatic individuals with the disorder. Therefore, in this review, the neurological findings of symptomatic individuals with profound biotinidase deficiency have been compiled to catalog the characteristic features of the disorder and the consequences of biotin treatment on these findings. In addition, based on the available evidence, I have speculated on the cause of neurological problems associated with the disorder. Future studies in biotinidase-deficient animals should allow us to demonstrate more definitively if these speculations are correct.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21696988     DOI: 10.1016/j.ymgme.2011.06.001

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  29 in total

1.  Clinical utility gene card for: biotinidase deficiency.

Authors:  Sébastien Küry; Vincent Ramaekers; Stéphane Bézieau; Barry Wolf
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

Review 2.  Early-onset epileptic encephalopathies and the diagnostic approach to underlying causes.

Authors:  Su-Kyeong Hwang; Soonhak Kwon
Journal:  Korean J Pediatr       Date:  2015-11-22

3.  Clinical pearls in pediatric neurology.

Authors:  Pratibha Singhi; Jitendra Kumar Sahu; Naveen Sankhyan; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2014-02-16       Impact factor: 1.967

4.  Detection of biotinidase gene mutations in Turkish patients ascertained by newborn and family screening.

Authors:  Mehmet Karaca; Rıza Köksal Özgül; Özlem Ünal; Didem Yücel-Yılmaz; Mustafa Kılıç; Burcu Hişmi; Ayşegül Tokatlı; Turgay Coşkun; Ali Dursun; Hatice Serap Sivri
Journal:  Eur J Pediatr       Date:  2015-03-11       Impact factor: 3.183

5.  "Think metabolic" in adults with diagnostic challenges: Biotinidase deficiency as a paradigm disorder.

Authors:  Barry Wolf
Journal:  Neurol Clin Pract       Date:  2017-12

6.  A Case of Biotinidase Deficiency in an Adult with Respiratory Failure in the Intensive Care Unit.

Authors:  Zerrin Demirtürk; Evren Şentürk; Abbas Köse; Perihan Ergin Özcan; Lütfi Telci
Journal:  Balkan Med J       Date:  2016-09-01       Impact factor: 2.021

Review 7.  Treatable Genetic Metabolic Epilepsies.

Authors:  Lama Assi; Youssef Saklawi; Pascale E Karam; Makram Obeid
Journal:  Curr Treat Options Neurol       Date:  2017-09       Impact factor: 3.598

8.  Rare Treatable Cause of Demyelinating Leukoencephalopathy That One Cannot Afford to Miss.

Authors:  Vykuntaraju K Gowda; Sukanya Vignesh; Balamurugan Nagarajan; Varunvenkat M Srinivasan; Manojna Battina; Maya Bhat; Rita Christopher
Journal:  J Pediatr Genet       Date:  2020-12-18

9.  Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.

Authors:  Erin T Strovel; Tina M Cowan; Anna I Scott; Barry Wolf
Journal:  Genet Med       Date:  2017-07-05       Impact factor: 8.822

10.  The Biotinidase Gene Variants Registry: A Paradigm Public Database.

Authors:  Melinda Procter; Barry Wolf; David K Crockett; Rong Mao
Journal:  G3 (Bethesda)       Date:  2013-04-09       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.